Fundraising Fox
Clare Ozawa
InvestorManaging Director at Versant Ventures
San Diego, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Clare
Sign up to see every warm intro you have to Clare
- Paths you didn't know you had: your email and LinkedIn already hold routes to Clare. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Clare Ozawa combines a Stanford Ph.D. with experience as COO/CBO at Inception Sciences, leads San Diego–Bay Area investments and sits on boards of Capsida, Lycia, Gate Bioscience and 858 Therapeutics.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Deals · 6
Lycia TherapeuticsBoard seat
via Versant Ventures · filed Jun 2026 · $75M raise
858 Therapeutics, Inc.Board seat
via Versant Ventures · filed Jul 2024 · $50.4M raise
Presbyopia TherapiesBoard seat
via Versant Ventures · filed Mar 2023 · $83.5M raise
March Therapeutics, Inc.Board seat
via Versant Ventures · filed Sep 2022 · $30.3M raise
Jengu Therapeutics, Inc.Board seat
via Versant Ventures · filed Sep 2020 · $50M raise
Mistral TherapeuticsBoard seat
via Versant Ventures · filed Jun 2018 · $59.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Oyster Point Pharmaceuticals
Investor
Capsida BiotherapeuticsContineum TherapeuticsGate BioKate TherapeuticsLENZ Therapeutics, Inc.
Sources: curated public sources · SEC Form D filings.
Colleagues at Versant Ventures
Network5
Investors connected to Clare in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Clare Ozawa?
- Clare Ozawa combines a Stanford Ph.D. with experience as COO/CBO at Inception Sciences, leads San Diego–Bay Area investments and sits on boards of Capsida, Lycia, Gate Bioscience and 858 Therapeutics.
- Where does Clare Ozawa work?
- Clare Ozawa is Managing Director at Versant Ventures.
- What does Clare Ozawa invest in?
- Clare Ozawa invests in Biotech, Healthtech, Medical Devices.
- What check size does Clare Ozawa write?
- Clare Ozawa typically writes checks of $100K – $5M.
- What boards does Clare Ozawa sit on?
- Clare Ozawa holds tracked board seats at 858 Therapeutics, Inc., Jengu Therapeutics, Inc., Lycia Therapeutics, March Therapeutics, Inc., Mistral Therapeutics, Presbyopia Therapies.
- What companies has Clare Ozawa invested in?
- Investments tracked here include Oyster Point Pharmaceuticals, 858 Therapeutics, Inc., Capsida Biotherapeutics, Contineum Therapeutics, Gate Bio, Kate Therapeutics, LENZ Therapeutics, Inc., Lycia Therapeutics.
- Does Clare Ozawa lead rounds?
- Yes — Clare Ozawa has led 1 tracked investment.
About this profile. Compiled from public sources — Versant Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights